Evolving Pharmacotherapies for the Treatment of Metastatic Melanoma

por Salama, April K.S.
Publicado 2013

Updates in Therapy for Advanced Melanoma

por Singh, Bhavana P., Salama, April K. S.
Publicado 2016

A Review of Immune-Mediated Adverse Events in Melanoma

por Kennedy, Lucy Boyce, Salama, April K. S.
Publicado 2019

Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy

por Tan, Irena, Malinzak, Michael, Salama, April K. S.
Publicado 2018

Checkpoint Inhibitors in Melanoma Patients with Underlying Autoimmune Disease

por Dietz, Hilary, Weinmann, Sophia C, Salama, April K
Publicado 2021

Rapid complete response of metastatic melanoma in a patient undergoing ipilimumab immunotherapy in the setting of active ulcerative colitis

por Bostwick, A Doran, Salama, April K, Hanks, Brent A
Publicado 2015

Checkpoint inhibitor use in two heart transplant patients with metastatic melanoma and review of high-risk populations

por Grant, Michael J, DeVito, Nicholas, Salama, April K S
Publicado 2018

Liver transplant patient with in-transit squamous cell carcinoma treated with talimogene laherparepvec

por Lebhar, Jamie, Jacobs, Jennifer, Faraz, Khushnood, Salama, April K.S., Mosca, Paul J.
Publicado 2023

Overall Survival Improved for Contemporary Patients with Melanoma: A 2004–2015 National Cancer Database Analysis

por Farrow, Norma E., Turner, Megan C., Salama, April K. S., Beasley, Georgia M.
Publicado 2020

Predictive factors of neoadjuvant immune checkpoint blockade in melanoma

por Sarver, Melissa, Brown, Michael C., Rhodin, Kristen E., Salama, April K. S., Beasley, Georgia M.
Publicado 2021

Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy

por Lowe, Jared R., Perry, Daniel J., Salama, April K. S., Mathews, Clayton E., Moss, Larry G., Hanks, Brent A.
Publicado 2016

Hazard-Rate Analysis and Patterns of Recurrence in Early Stage Melanoma: Moving towards a Rationally Designed Surveillance Strategy

por Salama, April K. S., de Rosa, Nicole, Scheri, Randall P., Pruitt, Scott K., Herndon, James E., Marcello, Jennifer, Tyler, Douglas S., Abernethy, Amy P.
Publicado 2013

Potential Utility of Synthetic D-Lactate Polymers in Skin Cancer

por Dikshit, Anushka, Lu, Junqi, Ford, Amy E., Degan, Simone, Jin, Yingai J., Sun, Huiying, Nichols, Amanda, Salama, April K.S., Beasley, Georgia, Gooden, David, Zhang, Jennifer Y.
Publicado 2021

Identification of a Germline Pyrin Variant in a Metastatic Melanoma Patient With Multiple Spontaneous Regressions and Immune-related Adverse Events

por Oswalt, Cameron J., Al-Rohil, Rami N., Theivanthiran, Bala, Haykal, Tarek, Salama, April K.S., DeVito, Nicholas C., Holtzhausen, Alisha, Ko, Dennis C., Hanks, Brent A.
Publicado 2022

Metastatic melanoma patients’ sensitivity to ipilimumab cannot be predicted by tumor characteristics

por Rossfeld, Kara, Hade, Erinn M., Gangi, Alexandra, Perez, Matthew, Kinsey, Emily N., Grabska, Joanna, Ederle, Ashley, Zager, Jonathan, Salama, April K., Olencki, Thomas E, Beasley, Georgia M
Publicado 2017

Operative and peri‐operative considerations in the management of brain metastasis

por Sankey, Eric W., Tsvankin, Vadim, Grabowski, Matthew M., Nayar, Gautam, Batich, Kristen A., Risman, Aida, Champion, Cosette D., Salama, April K. S., Goodwin, C. Rory, Fecci, Peter E.
Publicado 2019

Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma

por Amin, Asim, Lawson, David H., Salama, April K.S., Koon, Henry B., Guthrie, Troy, Thomas, Sajeve S., O’Day, Steven J., Shaheen, Montaser F., Zhang, Bin, Francis, Stephen, Hodi, F. Stephen
Publicado 2016

Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy

por DeVito, Nicholas C., Sturdivant, Michael, Thievanthiran, Balamayooran, Xiao, Christine, Plebanek, Michael P., Salama, April K.S., Beasley, Georgia M., Holtzhausen, Alisha, Novotny-Diermayr, Veronica, Strickler, John H., Hanks, Brent A.
Publicado 2021

OTHR-14. An immunogenomic analysis of melanoma brain metastases (MBM) compared to extracranial metastases (ECM)

por Kennedy, Lucy Boyce, Van Swearingen, Amanda E D, Sheng, Jeff, Zhang, Dadong, Qin, Xiaodi, Lipp, Eric, Kumar, Swaminathan, Zhang, Gao, Hanks, Brent, Davies, Michael, Owzar, Kouros, Anders, Carey K, Salama, April K S
Publicado 2021

Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study

por Hamid, Omid, Hassel, Jessica C, Shoushtari, Alexander N, Meier, Friedegund, Bauer, Todd M, Salama, April K S, Kirkwood, John M, Ascierto, Paolo A, Lorigan, Paul C, Mauch, Cornelia, Orloff, Marlana, Evans, Thomas R Jeffry, Holland, Chris, Edukulla, Ramakrishna, Abedin, Shaad E, Middleton, Mark R
Publicado 2023